GILEAD SCIENCES, INC. - Common Stock (GILD)

Historical Holders from Q1 2014 to Q4 2025

Type / Class: Equity / Common Stock
Symbol: GILD on Nasdaq
Shares outstanding: 1,240,722,841
Price per share: $122.74
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 1,051,848,208
Holdings value: $116,773,897,226
% of all portfolios: 0.05%
Share change: -20,468,935
Value change: -$2,276,423,125
Average buys %: +0.01%
Average sells %: -0.01%
Number of holders: 1,995
Price from insider filings: $121.60

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of GILEAD SCIENCES, INC. - Common Stock (GILD) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	8.2%		$10,543,240,861		101,739,273		BlackRock, Inc.	31 Mar 2025
Capital World Investors	4.3%		$5,578,907,889		53,834,873		Capital World Investors	31 Mar 2025

As of 30 Sep 2025, GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,995 institutional shareholders filing 13F forms. They hold 1,051,848,208 shares of 1,240,722,841 outstanding shares (85%) .

Top 25 institutional shareholders own 59% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	9.6%	118,983,644	-0.32%	0.2%	$13,207,184,484
BlackRock, Inc.	9.4%	116,281,391	+1.2%	0.23%	$12,907,234,450
FMR LLC	4.9%	60,316,279	+0.6%	0.35%	$6,695,106,838
STATE STREET CORP	4.8%	59,089,305	-0.17%	0.23%	$6,558,912,855
Capital World Investors	3.6%	45,179,931	-2.4%	0.69%	$5,015,468,946
Dodge & Cox	2.4%	30,133,131	-2.2%	1.8%	$3,344,777,541
Capital Research Global Investors	2.4%	30,014,046	-3.5%	0.63%	$3,331,573,238
GEODE CAPITAL MANAGEMENT, LLC	2.4%	29,928,986	+2.5%	0.21%	$3,309,304,358
PRICE T ROWE ASSOCIATES INC /MD/	2.1%	26,503,391	+12%	0.31%	$2,941,877,000
WELLINGTON MANAGEMENT GROUP LLP	2.1%	25,618,534	-32%	0.5%	$2,843,657,274
MORGAN STANLEY	1.9%	23,734,776	+3.9%	0.16%	$2,634,560,501
JPMORGAN CHASE & CO	1.7%	21,164,635	+11%	0.15%	$2,349,304,567
BANK OF AMERICA CORP /DE/	1.6%	20,138,832	+6.1%	0.17%	$2,235,410,374
Invesco Ltd.	1.2%	15,139,681	+12%	0.26%	$1,680,504,605
NORTHERN TRUST CORP	1.2%	14,316,656	-0.64%	0.2%	$1,589,148,816
Bank of New York Mellon Corp	1.1%	14,248,353	+3.8%	0.28%	$1,581,567,161
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC	1%	12,988,515	-22%	0.31%	$1,441,725,165
Legal & General Group Plc	0.82%	10,210,599	+4.2%	0.25%	$1,133,376,489
DIMENSIONAL FUND ADVISORS LP	0.77%	9,557,768	-5.6%	0.23%	$1,061,087,480
DEUTSCHE BANK AG\	0.72%	8,955,289	+45%	0.33%	$994,037,079
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.64%	7,930,860	-0.87%	0.14%	$880,325,460
Amundi	0.61%	7,583,781	-28%	0.28%	$861,365,845
ROYAL BANK OF CANADA	0.59%	7,327,676	+5.7%	0.14%	$813,370,000
AMERIPRISE FINANCIAL INC	0.58%	7,148,405	+5.9%	0.18%	$793,506,386
GOLDMAN SACHS GROUP INC	0.57%	7,121,802	+14%	0.11%	$790,520,035

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	9,366,644	$1,147,576,973	-$219,047,160			$122.74	92
2025 Q3	1,051,848,208	$116,773,897,226	-$2,276,423,125	$752,104,774	$885,028,546	$111.00	1,995
2025 Q2	1,073,254,023	$118,963,159,666	+$3,514,130,558	$945,276,027	$1,269,581,823	$110.87	2,000
2025 Q1	1,041,713,276	$116,699,126,655	-$1,850,488,506	$1,054,254,689	$1,032,439,799	$112.05	1,983
2024 Q4	1,060,979,792	$97,956,932,954	+$3,227,411,609	$837,352,010	$769,503,942	$92.37	1,847
2024 Q3	1,022,629,124	$85,749,288,134	-$935,871,757	$815,607,330	$864,801,437	$83.84	1,701
2024 Q2	1,033,439,494	$70,880,576,523	+$951,368,462	$612,865,050	$809,851,328	$68.61	1,650
2024 Q1	1,023,306,837	$74,925,010,043	-$1,831,705,930	$585,726,773	$626,877,914	$73.25	1,695
2023 Q4	11,049,335	$895,175,701	+$167,444,979			$81.01	28
2023 Q3	1,019,421,806	$76,447,404,391	-$114,843,377	$673,797,976	$742,408,356	$74.94	1,640
2023 Q2	1,024,264,154	$78,981,311,540	-$1,101,154,807	$572,441,489	$733,286,706	$77.07	1,657
2023 Q1	1,029,454,306	$85,376,729,693	+$634,575,528	$671,755,922	$759,430,549	$82.97	1,690
2022 Q4	1,026,653,469	$88,138,481,241	+$2,234,046,829	$1,009,823,353	$1,014,231,647	$85.85	1,720
2022 Q3	999,388,106	$61,698,289,975	+$668,089,822	$615,220,224	$812,907,882	$61.69	1,545
2022 Q2	989,863,619	$61,085,016,650	+$251,754,965	$581,853,794	$790,030,169	$61.81	1,560
2022 Q1	983,518,897	$58,461,421,407	-$867,133,541	$1,042,947,145	$1,100,689,610	$59.45	1,543
2021 Q4	1,005,000,106	$72,974,074,102	+$423,205,992	$1,713,706,409	$1,447,941,776	$72.61	1,644
2021 Q3	999,943,649	$69,858,219,921	+$698,452,807	$1,416,183,075	$1,281,737,830	$69.85	1,532
2021 Q2	990,439,952	$68,199,959,986	+$816,880,406	$1,357,943,968	$1,414,331,940	$68.86	1,514
2021 Q1	978,677,128	$63,183,473,454	+$783,832,858	$1,426,536,513	$1,546,309,034	$64.63	1,541
2020 Q4	969,073,542	$56,416,352,920	-$213,146,922	$1,461,635,417	$1,207,488,372	$58.26	1,527
2020 Q3	974,558,571	$61,524,440,258	-$1,193,375,872	$1,654,846,574	$1,189,178,876	$63.19	1,507
2020 Q2	989,091,464	$76,031,513,491	-$602,157,685	$1,801,727,151	$1,523,272,691	$76.94	1,602
2020 Q1	995,243,753	$74,377,682,805	-$931,666,383	$1,695,731,006	$2,037,303,000	$74.76	1,618
2019 Q4	1,013,277,041	$65,829,218,929	+$41,599,226	$1,247,196,002	$1,259,439,000	$64.98	1,533
2019 Q3	1,012,747,536	$64,172,869,879	-$326,836,721	$959,445,000	$651,826,000	$63.38	1,443
2019 Q2	1,015,244,088	$68,569,551,610	+$2,180,517,856	$900,646,000	$738,353,000	$67.56	1,459
2019 Q1	1,014,779,631	$65,956,811,798	-$280,528,429	$930,522,000	$686,379,000	$65.01	1,462
2018 Q4	1,019,156,580	$63,697,302,656	+$45,594,695	$1,136,732,000	$807,377,000	$62.55	1,467
2018 Q3	1,015,815,788	$78,354,775,957	+$2,232,214,471	$1,417,295,001	$974,175,000	$77.21	1,510
2018 Q2	992,759,010	$70,276,372,241	-$1,488,544,245	$1,573,497,002	$931,090,000	$70.84	1,508
2018 Q1	1,023,215,890	$77,042,114,031	+$340,327,290	$1,773,069,636	$1,556,627,140	$75.39	1,547
2017 Q4	1,021,324,122	$73,108,560,217	+$1,045,755,331	$2,388,004,847	$1,484,790,752	$71.64	1,560
2017 Q3	1,004,278,813	$81,345,014,456	+$2,386,552,495	$2,353,871,003	$1,676,796,006	$81.02	1,491
2017 Q2	977,601,547	$69,174,199,021	+$272,397,940	$2,095,949,001	$1,569,515,015	$70.78	1,507
2017 Q1	975,098,210	$66,197,700,440	+$5,270,971,838	$2,020,140,072	$1,286,837,019	$67.92	1,506
2016 Q4	990,948,673	$70,954,014,933	-$516,375,290	$1,868,992,039	$1,690,121,033	$71.61	1,555
2016 Q3	994,060,931	$78,592,864,942	-$3,899,932,865	$2,239,692,506	$1,913,974,333	$79.12	1,538
2016 Q2	1,038,853,265	$86,643,338,806	-$2,511,339,572	$1,679,313,000	$1,157,814,000	$83.42	1,581
2016 Q1	1,067,873,176	$98,085,234,299	-$6,103,030,916	$1,602,034,080	$1,414,042,480	$91.86	1,615
2015 Q4	1,137,810,592	$115,076,911,741	-$3,125,335,735	$2,415,183,000	$1,864,171,000	$101.19	1,616
2015 Q3	1,164,185,127	$114,300,378,967	-$3,455,659,343	$2,808,943,000	$1,800,897,000	$98.19	1,558
2015 Q2	1,151,002,620	$134,743,314,628	-$3,632,207,721	$3,183,989,000	$1,786,803,634	$117.08	1,545
2015 Q1	1,232,552,622	$120,997,326,729	-$2,160,408,891	$3,356,644,000	$2,196,327,000	$98.13	1,479
2014 Q4	1,258,287,161	$118,676,792,007	-$4,582,958,195	$4,064,088,000	$2,859,650,000	$94.26	1,421
2014 Q3	1,293,744,104	$137,720,230,918	-$9,496,064,841	$3,472,654,000	$2,265,970,000	$106.45	1,312
2014 Q2	1,349,503,518	$111,909,950,508	-$6,394,423,351	$2,273,311,000	$1,838,862,000	$82.91	1,248
2014 Q1	1,401,939,658	$99,346,776,114	-$715,988,992	$2,128,829,000	$1,115,263,000	$70.86	1,170